Authors: Casonato, A Pontara, E Sartorello, F Bertomoro, A Durante, C Girolami, A

Citation: A. Casonato et al., Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization, J LA CL MED, 137(1), 2001, pp. 70-76

Authors: Casonato, A Pontara, E Bertomoro, A Sartorello, F Cattini, MG Girolami, A

Citation: A. Casonato et al., Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?, BR J HAEM, 112(3), 2001, pp. 578-583

Authors: Bilora, F Dei Rossi, C Girolami, B Casonato, A Zanon, E Bertomoro, A Girolami, A

Citation: F. Bilora et al., Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects bymeans of carotid echo-color Doppler scan, CL APPL T-H, 5(4), 1999, pp. 232-235

Authors: Girolami, A Zanon, E Bertomoro, A Gavasso, S Fadin, M

Citation: A. Girolami et al., Combined factor V and factor VII deficiency due to an independent segregation of the two defects, CL APPL T-H, 5(2), 1999, pp. 136-138

Authors: Zanon, E Zerbinati, P Girolami, B Bertomoro, A Girolami, A

Citation: E. Zanon et al., Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates, BL COAG FIB, 10(3), 1999, pp. 117-120

Authors: Casonato, A Pontara, E Bertomoro, A Sartorello, F Girolami, A

Citation: A. Casonato et al., Which assay is the most suitable to investigate von Willebrand factor functional activity?, THROMB HAEM, 81(6), 1999, pp. 994-995